Screening of flavonoid aglycons’ metabolism mediated by the human liver cytochromes P450

Biological effects of flavonoids have been extensively studied in the last 80 years. As flavonoids represent a rather large group of compounds, data on metabolic biotransformations of these compounds is relatively limited to those well studied. The objective of this study was to screen the metabolis...

Full description

Saved in:
Bibliographic Details
Main Authors: Benković Goran, Bojić Mirza, Maleš Željan, Tomić Siniša
Format: Article
Language:English
Published: Sciendo 2019-12-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2019-0039
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832570159097708544
author Benković Goran
Bojić Mirza
Maleš Željan
Tomić Siniša
author_facet Benković Goran
Bojić Mirza
Maleš Željan
Tomić Siniša
author_sort Benković Goran
collection DOAJ
description Biological effects of flavonoids have been extensively studied in the last 80 years. As flavonoids represent a rather large group of compounds, data on metabolic biotransformations of these compounds is relatively limited to those well studied. The objective of this study was to screen the metabolism of 30 selected flavonoid aglycons mediated by the most relevant metabolic enzymes, human liver cytochromes P450. For this purpose, in vitro experiments with human liver microsomes and recombinant enzymes were conducted. To evaluate flavonoid’s metabolism and structure of the products, high-performance liquid chromatography coupled with high-resolution mass spectrometry was used. Out of 30 flavonoids, 15 were susceptible to oxidative metabolism mediated by cytochromes P450. Dominant reactions were aromatic hydroxylation and O-demethylation, or a combination of these reactions. The dominant enzyme responsible for the observed metabolic reactions is CYP1A2, whereas other human liver cytochromes P450, namely, CYP2C19, CYP2D6, CYP2E1 and CYP3A4, contribute to flavonoid metabolism to a lesser degree. These results, to some extent, contribute to the understanding of the metabolism of constituents found in antioxidant dietary supplements and their possible interactions with other xenobiotics, i.e., medicinal products.
format Article
id doaj-art-aeff53cf885244ca969d94f33c29ccb9
institution Kabale University
issn 1846-9558
language English
publishDate 2019-12-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-aeff53cf885244ca969d94f33c29ccb92025-02-02T17:01:54ZengSciendoActa Pharmaceutica1846-95582019-12-0169454156210.2478/acph-2019-0039acph-2019-0039Screening of flavonoid aglycons’ metabolism mediated by the human liver cytochromes P450Benković Goran0Bojić Mirza1Maleš Željan2Tomić Siniša3Agency for Medicinal Products and Medical Devices, HR-10000ZagrebCroatiaUniversity of Zagreb, Faculty of Pharmacy and Biochemistry Department of Medicinal ChemistryHR-10000Zagreb, CroatiaUniversity of Zagreb, Faculty of Pharmacy and Biochemistry Department of Pharmaceutical BotanyHR-10000Zagreb, CroatiaAgency for Medicinal Products and Medical Devices, HR-10000ZagrebCroatiaBiological effects of flavonoids have been extensively studied in the last 80 years. As flavonoids represent a rather large group of compounds, data on metabolic biotransformations of these compounds is relatively limited to those well studied. The objective of this study was to screen the metabolism of 30 selected flavonoid aglycons mediated by the most relevant metabolic enzymes, human liver cytochromes P450. For this purpose, in vitro experiments with human liver microsomes and recombinant enzymes were conducted. To evaluate flavonoid’s metabolism and structure of the products, high-performance liquid chromatography coupled with high-resolution mass spectrometry was used. Out of 30 flavonoids, 15 were susceptible to oxidative metabolism mediated by cytochromes P450. Dominant reactions were aromatic hydroxylation and O-demethylation, or a combination of these reactions. The dominant enzyme responsible for the observed metabolic reactions is CYP1A2, whereas other human liver cytochromes P450, namely, CYP2C19, CYP2D6, CYP2E1 and CYP3A4, contribute to flavonoid metabolism to a lesser degree. These results, to some extent, contribute to the understanding of the metabolism of constituents found in antioxidant dietary supplements and their possible interactions with other xenobiotics, i.e., medicinal products.https://doi.org/10.2478/acph-2019-0039flavonoidshuman liver cytochromes p450metabolismhplcms
spellingShingle Benković Goran
Bojić Mirza
Maleš Željan
Tomić Siniša
Screening of flavonoid aglycons’ metabolism mediated by the human liver cytochromes P450
Acta Pharmaceutica
flavonoids
human liver cytochromes p450
metabolism
hplc
ms
title Screening of flavonoid aglycons’ metabolism mediated by the human liver cytochromes P450
title_full Screening of flavonoid aglycons’ metabolism mediated by the human liver cytochromes P450
title_fullStr Screening of flavonoid aglycons’ metabolism mediated by the human liver cytochromes P450
title_full_unstemmed Screening of flavonoid aglycons’ metabolism mediated by the human liver cytochromes P450
title_short Screening of flavonoid aglycons’ metabolism mediated by the human liver cytochromes P450
title_sort screening of flavonoid aglycons metabolism mediated by the human liver cytochromes p450
topic flavonoids
human liver cytochromes p450
metabolism
hplc
ms
url https://doi.org/10.2478/acph-2019-0039
work_keys_str_mv AT benkovicgoran screeningofflavonoidaglyconsmetabolismmediatedbythehumanlivercytochromesp450
AT bojicmirza screeningofflavonoidaglyconsmetabolismmediatedbythehumanlivercytochromesp450
AT maleszeljan screeningofflavonoidaglyconsmetabolismmediatedbythehumanlivercytochromesp450
AT tomicsinisa screeningofflavonoidaglyconsmetabolismmediatedbythehumanlivercytochromesp450